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Abstract
Background: Trypanosomes can synthesize polyunsaturated fatty acids. Previously, we have shown that they possess
stearoyl-CoA desaturase (SCD) and oleate desaturase (OD) to convert stearate (C18) into oleate (C18:1) and linoleate (C18:2),
respectively. Here we examine if OD is essential to these parasites.
Methodology: Cultured procyclic (insect-stage) form (PCF) and bloodstream-form (BSF) Trypanosoma brucei cells were
treated with 12- and 13-thiastearic acid (12-TS and 13-TS), inhibitors of OD, and the expression of the enzyme was knocked
down by RNA interference. The phenotype of these cells was studied.
Principal Findings: Growth of PCF T. brucei was totally inhibited by 100 mM of 12-TS and 13-TS, with EC50 values of 4062
and 3062 mM, respectively. The BSF was more sensitive, with EC50 values of 763 and 261 mM, respectively. This growth
phenotype was due to the inhibitory effect of thiastearates on OD and, to a lesser extent, on SCD. The enzyme inhibition
caused a drop in total unsaturated fatty-acid level of the cells, with a slight increase in oleate but a drastic decrease in
linoleate level, most probably affecting membrane fluidity. After knocking down OD expression in PCF, the linoleate content
was notably reduced, whereas that of oleate drastically increased, maintaining the total unsaturated fatty-acid level
unchanged. Interestingly, the growth phenotype of the RNAi-induced cells was similar to that found for thiastearate-treated
trypanosomes, with the former cells growing twofold slower than the latter ones, indicating that the linoleate content itself
and not only fluidity could be essential for normal membrane functionality. A similar deleterious effect was found after RNAi
in BSF, even with a mere 8% reduction of OD activity, indicating that its full activity is essential.
Conclusions/Significance: As OD is essential for trypanosomes and is not present in mammalian cells, it is a promising
target for chemotherapy of African trypanosomiasis.
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Introduction
Trypanosomes are parasitic flagellated protists belonging to
the family Trypanosomatidae (order Kinetoplastida) of which
many members cause human diseases. Trypanosoma brucei is
responsible for human sleeping sickness in sub-Saharan Africa
and Trypanosoma cruzi causes Chagas’ disease in Latin America.
Few drugs are available against these diseases and those
currently used are toxic and the parasites are susceptible to
generate resistance against them. It makes urgent the develop-
ment of more safe and efficacious drugs, as well as the
identification of new targets.
T. brucei multiplies extracellularly in mammals as the blood-
stream form (BSF) of the parasite. In advanced stages of the
disease, trypanosomes traverse the blood-brain barrier and invade
the cerebrospinal fluid. The long-slender BSF differentiates into a
non-replicative short-stumpy form that, upon ingestion by the
tsetse fly during a blood meal, differentiates into the procyclic form
(PCF) that dwells into the insect’s midgut. Inside the insect, the
PCF changes successively into various other developmental stages
while moving from the gut to the salivary glands. Finally, the
parasite can be transmitted to a new mammalian host as the
metacyclic form, with the saliva of the tsetse during another blood
meal [1]. Cells of the metacyclic form and BSF are densely
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surface glycoprotein (VSG). The regular switching to the
expression of a different VSG (‘‘antigenic variation’’) allows the
parasite population to evade the immune system [2].
For many years it was known that T. cruzi and PCF T. brucei are
capable of synthesizing fatty acids (FA), but it was believed that
BSF African trypanosomes were entirely dependent on their host
for their lipid content. However, recently it was reported that in
addition to the uptake of host lipoproteins, BSFs are also able to
synthesize de novo their own FAs through an unprecedented
mechanism [3]. Short- and medium-chain FAs are usually
synthesized by means of the soluble fatty-acid synthetase (FAS)
systems and subsequently elongated to long and very long FAs by
the particulate elongase (ELO) system that resides in the
endoplasmic reticulum [4]. Trypanosomatids lack the classic
eukaryote or type I FAS but conserve a mitochondrial type II FAS
[5]. This latter system is mainly involved in the production of
octanoate for lipoic acid synthesis and contributes only to a small
fraction of total FA biosynthesis for use in the mitochondrion. The
main FA pool is synthesized by a specialized ELO system that
appears to be an adaptation to the parasitic lifestyle [6]. T. brucei
has three ELOs responsible for the successive elongation of
butyryl-CoA to decanoyl-CoA (ELO1), then to myristoyl-CoA
(ELO2) and finally to stearoyl-CoA (ELO3). This modular
synthesis allows the parasite to regulate the production of different
intermediates as required throughout its life cycle. For example, by
repression of ELO3 the BSF accumulates myristoyl-CoA, to
supply part of the paramount requirements of C14 moieties in the
synthesis of the glycosylphosphatidylinositol (GPI) anchor of VSGs
[6,7]. T. cruzi has an additional ELO (ELO4) [6,8] which elongates
C18, and probably C16, to C24 and C26 FAs (Livore and Uttaro,
unpublished results), required in the synthesis of anchors for
surface macromolecules, such as mucins and glycoinositol
phospholipids. The ELO pathway and the mitochondrial FAS
appear to be essential in T. brucei, consequently being potential
targets for the development of new trypanocidal drugs. For
instance, the antibiotic thiolactomycin seems to inhibit both
pathways and kills cultured parasites with an EC50 of 150 mM [6].
The stearate (C18:0) synthesized by the trypanosomatid ELO
system is mainly converted into linoleate (C18:2). Linoleate
represents near 30% and 40% of total FAs in T. brucei and T.
cruzi, respectively, being the principal acyl moiety in membrane
phospholipids. Total unsaturated FAs can represent up to 70% of
FAs depending of the parasite species and life cycle stage [9,10].
We have recently described the pathway of polyunsaturated FA
(PUFA) biosynthesis in trypanosomatids. Leishmania major, also
belonging to the Trypanosomatidae, has a complete set of eight
enzymes that allow the parasite to synthesize C22:5 and C22:6
PUFAs from C18:0. By contrast, T. brucei and T. cruzi desaturate
C18:0 to oleate (C18:1) by means of the stearoyl-CoA D9
desaturase (SCD) and then to C18:2 by the oleate D12 desaturase
(OD) [11]. Linoleate cannot be further desaturated nor elongated
as trypanosomes lack the enzymes linoleate D15 desaturase, D6
C18 desaturase, D6 PUFA ELO and D5 C20 desaturase.
However, up to 20% of the trypanosome’s total FAs are C22
PUFAs. These are synthesized from the intermediates arachido-
nate (C20:4n6) and eicosapentaenoate (C20:5n3) taken up from
the host, which are elongated by a D5 PUFA ELO and
desaturated by a D4 C22 desaturase [8,12]. Such proportion of
unsaturated FAs could provide the cell with a high membrane
fluidity that may be essential for the parasites to adapt themselves
to the dramatic changes in temperature and chemical parameters
experienced during their complex life cycles. For this reason we
speculated that the biosynthesis of linoleate has to be essential in
trypanosomes. In addition, OD is not present in mammals
highlighting this enzyme as a putative selective chemotherapeutic
target. We have recently shown that oleate and linoleate
biosynthesis can be specifically inhibited in T. cruzi [13]. Isoxyl
(Thiocarlide) and 10-thiastearate (10-TS) inhibited the growth of
the parasite with EC50 values of 2 and mM, respectively, due to the
specific inhibition of SCD, reducing the level of oleate and, as a
consequence, also linoleate in the membrane. Moreover, OD was
specifically inhibited by 12- and 13-TS isomers, producing a
drastic drop in both the linoleate content of T. cruzi epimastigotes
and in parasite growth (with EC50 values of 50 and 10 mM,
respectively). TS positional isomers are analogues of C18:0 with
sulphur atoms substituting methylene groups in the carbon chain.
As introducing sulphur atoms has little effect on the structure of
the aliphatic chain, thia fatty acids are metabolized as ordinary
FAs and incorporated into different lipid classes [14]. 9- and 10-
TS were shown to be converted to the corresponding acyl-CoAs
and to bind to hepatocyte’s SCD, causing strong inhibition of D9
desaturation [15]. The same compounds had been earlier tested
on cultures of the trypanosomatids Crithidia fasciculata and
Leishmania sp., although as inhibitors of dihydrosterculic acid
biosynthesis. This cyclopropane FA is exclusively synthesized by
eukaryotic microbes such as species of Crithidia, Herpetomonas,
Leptomonas and Leishmania, but not by trypanosomes or vertebrates,
suggesting dihydrosterculic acid biosynthesis as a putative target
for selective chemotherapy of leishmaniasis [16,17]. However, our
results (as obtained with T. cruzi) suggested that the deleterious
effect, at least for 10-TS, was most probably due to a specific
inhibition of the SCD and a consequent drop in levels of essential
FAs such as oleate and linoleate, in the Leishmania’s membranes
[13].
In the work presented in this paper we show that, like in T. cruzi,
T. brucei OD can be inhibited by 12- and 13-TS in both PCF and
the infective BSF, with a consequent drop in linoleate content and
growth inhibition. Knock-down of OD gene expression by RNA
interference (RNAi) in T. brucei PCF and BSF produced similar
decreases of linoleate content and growth rate to that found upon
administering TSs. It validates OD as a promising target for the
development of selective chemical intervention.
Materials and Methods
Materials
Stearate, linoleate, oleate and sodium methoxide were obtained
from Sigma-Aldrich (St. Louis, MI, USA). All organic solvents
were purchased from Merck (Whitehouse Station, NJ, USA).
Thiastearic acid positional isomers were synthesized as previously
described [18], using reagents purchased from Sigma-Aldrich. For
argentation-thin layer chromatography (argentation-TLC), silica
gel plates (containing 10% silver nitrate) were purchased from
Analthech (Analthech, Inc., Newark, DE).
Trypanosomes, growth conditions and transfection
Bloodstream and procyclic forms of T. brucei Lister 427, cell lines
90-13 and 29-13, respectively [19] that were used in this study,
harbour chromosomically integrated constructs with the genes of
the T7 RNA polymerase and the Escherichia coli tetracycline (tet)
repressor. The parasites were always cultured in the presence of
G418 and hygromycin in order to maintain the respective
constructs. BSF were cultured in HMI-9 medium containing
10% heat-inactivated foetal calf serum (Invitrogen) and 2.5 mg/ml
G418 (Invitrogen) at 37uC under water-saturated air with 5%
CO2. PCF were grown in SDM-79 medium [20] supplemented
with 15% foetal calf serum and 50 mg/ml hygromycin (Sigma-
T. brucei OD Is a Drug Target
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with 5% CO2. Cultures were always harvested in the exponential
growth phase, i.e., at densities lower than 2610
6 cells/ml for BSF
and 2610
7 cells/ml for PCF, by centrifugation at 1,0006g for
10 min.
Transfection of trypanosomes and selection of clones were
performed as described previously [21]. After transfection and
selection, clones harbouring the recombinant construct used in the
transfection were stored at 280uC in appropriate medium
containing 12% glycerol.
Thiastearates, linoleate and oleate were added to the cultures as
solutions in ethanol. The final concentration of ethanol in the
cultures was always adjusted to 1%. Cultures were propagated by
dilution with fresh medium with the corresponding concentrations
of drugs. Cells were counted immediately before dilutions by using
a Neubauer chamber. Growth curves were plotted as the product
of cell density and total dilution versus time. Although no
significant effect of ethanol was seen on growth, we performed
for each experiment a control in which only the solvent was added
to the culture. The growth curves were highly reproducible.
Figures were drawn by using the mean 6 SD values of three
independent experiments. EC50 indicates the concentration of
drug required to cause 50% inhibition of the growth rate.
Although the indicated EC50 values were calculated by using the
last points of the growth curves, almost identical values were found
irrespective the day of treatment used to determine them.
Fatty-acid analysis
Cells (2610
8) in the late logarithmic phase of growth were
collected by centrifugation and the pellets washed twice with 8 ml of
Figure 1. Gas chromatography profile of total fatty acids from Trypanosoma brucei cells. Procyclic form (PCF) (A). Bloodstream form (BSF)
(B). Pool 1 indicates those fatty acids which are de novo synthesized by the parasite cells and partially taken up from the culture media; pool 2
indicates fatty acids taken up from the culture media plus those resulting from their elongation and desaturation.
doi:10.1371/journal.pone.0014239.g001
T. brucei OD Is a Drug Target
PLoS ONE | www.plosone.org 3 December 2010 | Volume 5 | Issue 12 | e14239isotonic saline solution. Lipids were extracted according to Bligh
andDyer [22].Theorganicphasewasreduced todryness underN2,
and FA methyl esters were prepared by adding 1 ml of 0.5 M
sodium methoxide in methanol and incubating for 20 min at room
temperature. After neutralization with 6 M HCl and extraction
with 2 ml hexane, the organic solvent was evaporated to dryness
under a N2 stream. FA methyl ester composition was analyzed with
a polyethylene glycol column (PE-WAX, 30 m60.25 mm inside
diameter, Perkin Elmer, Norwalk, CT, USA) in a Perkin Elmer
AutoSystem XL gas chromatograph. Gas chromatographic analysis
was performed at 180uC isothermically. The GC-MS was carried
out using a Perkin Elmer mass detector (model TurboMass)
operated at an ionization voltage of 70 eV with a scan range of
20–500 Da. The retention time and mass spectrum of any new peak
Figure 2. Effect of 13-thiastearate on the growth of procyclic-
form Trypanosoma brucei. Growth curves are presented of cells
cultured in the absence (control) or presence of increasing concentra-
tions of 13-thiastearate (13-TS). The results are means 6 SD of three
independent experiments.
doi:10.1371/journal.pone.0014239.g002
Table 1. Relative fatty-acid composition of procyclic and
bloodstream forms of Trypanosoma brucei.
Fatty acid PCF BSF
control 12-TS 13-TS
14:0 0.360.1 2.360.2 1.760.1 0.960.1
16:0 8.263.1 20.962.3 20.462.5 14.962.1
16:1 1.760.1 2.660.4 2.360.8 1.760.4
17:1 3.061.1 2.960.8 2.260.4 1.460.1
18:0 10.460.5 12.761.1 13.062.4 14.861.2
18:1 D9 16.562.1 18.261.9 18.861.3 11.160.9
18:1 D11 4.260.2 4.160.3 3.660.2 3.860.4
18:2 30.761.6 13.361.5 11.960.4 34.063.1
20:0 ,0.2 - - 0.660.2
20:1 0.360.1 0.460.2 0.460.1 0.860.1
20:2 0.760.4 2.660.8 2.260.6 0.460.2
20:3 n-6 1.660.7 1.960.4 2.160.3 0.660.1
20:3 n-3 0.2060.01 - - 0.660.2
20:4 n-6 2.060.5 3.060.7 2.860.3 1.960.4
20:5 n-3 ,0.2 - - -
22:4 n-3 1.760.4 0.260.1 1.360.1 0.760.2
22:5 n-6 5.462.1 3.060.6 3.760.5 3.861.1
22:5 n-3 1.260.3 1.760.2 1.560.3 1.160.3
22:6 11.764.5 9.462.7 12.061.8 6.361.8
Fatty acid composition (%) of procyclic form (PCF) was analysed before and
after treatment with 100 mM thiastearate isomers (12-TS and 13-TS). BSF,
bloodstream form.
doi:10.1371/journal.pone.0014239.t001
Figure 3. RNA interference of oleate desaturase expression in
procyclic-form trypanosomes. Growth curves (logarithmic plot) of
procyclic-form cell line 29-13 wild-type cells (wt PCF) and cells
transfected with a construct for RNAi of OD. Cells of the transfected
clone were cultured in the absence (-tet) and presence of tetracycline
(+tet) to induce RNA interference (A). Relative levels of OD mRNA,
normalized to tubulin mRNA levels. The results are expressed as
percentage of the normalized OD transcripts present in the untrans-
fected control (wt) cells and are the means 6 SD of three independent
experiments (B).
doi:10.1371/journal.pone.0014239.g003
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those available in the database NBS75K (National Bureau of
Standards). Percentages of FAs were calculated after integration of
the chromatogram peaks. Figures were drawn by using the mean 6
SD values of three independent experiments.
Whole-cell radiolabeling and analysis of fatty acids
T. brucei cells in the logarithmic phase of growth were collected
and resuspended in the same medium without serum at 10
7 cells/
ml. One ml of cell suspension was incubated at 20uC after addition
of 5 ml of [1-
14C]-stearic acid or [1-
14C]-oleic acid (American
Radiolabeled Chemicals Inc., St. Louis, MO) to a 70 mM final
concentration (specific activity 36 mCi/mmol) in fatty-acid free
albumin (1% final concentration), and 5 ml of desaturase inhibitor
or the same volume of ethanol. The incubation was stopped by
addition of 6 ml of chloroform/methanol (1:2 v/v). After 2 min of
vortexing, 2 ml of water and 2 ml of chloroform were added,
vortexed again and centrifuged for 5 min at 2,0006g. The organic
phase was recovered and washed with 4 ml of 2 M KCl by fraction
partition, dried under a N2 stream and treated as described before,
to obtain the FA methyl esters by transesterification. Methyl esters
were subjected to argentation-TLC, using toluene as developing
solvent [23]. Radioactivity was detected on a Typhoon 9200
PhosphorImager and, after the spots had been scraped from the
plate, quantified by liquid scintillation radioassay.
RNA interference
The T. brucei specific vector pZJM [24] was used to generate
stable cell lines of both PCF and BSF trypanosomes for the tet-
inducible expression of double-stranded RNA of OD. Double-
stranded RNA was produced by transcription of a construct
comprising a fragment representing the first half of the coding
region of the gene (GenBank ID: AY372529). To minimize the
possibility of nonspecific, off-target RNA degradation the gene
fragment selected for making the RNAi construct was checked by
performing a BLAST search against the T. brucei genome
database. No DNA sequences with significant similarity were
found. The construct was prepared by PCR amplification using
the following oligonucleotides: forward primer 59–ATAAGCT-
TATGTTGCCTAAGCAACAG–39 (HindIII site underlined) and
reverse primer 59–CCCTCGAGGGTGTGTTTATGGTGAG-
T–39 (XhoI site underlined). The sequence of the amplified DNA
was checked before it was inserted between the two tet-inducible
T7 promoters of vector pZJM, containing a gene for phleomycin
resistance (ble). The linearized recombinant pZJM-OD plasmid
was targeted for integration by homologous recombination into
the transcriptionally silent ribosomal RNA gene repeat spacer of
the T. brucei genome. Transfections of trypanosomes and selection
of clones were performed as described, using 1.25 and 2.5 mg/ml
phleomycin (Sigma-Aldrich) [24], respectively for BSF and PCF
[21,24], concentrations at which all wild-type cells died within 12
days, whereas a few clones could be obtained that survived and
grew normally during long-term cultivation. In order to confirm
the genomic integration of the plasmid, DNA was isolated from
the selected BSF OD RNAi cell line (propagated for many
generations after transfection with the not-autonomously replicat-
ing plasmid) as well as the non-transfected (wild-type) BSF 90.13
and PCF 29.13 lines, using the PureLink Genomic DNA mini kit
(Invitrogen). Genomic integration of the pZJM-OD DNA was then
checked by PCR, by amplifying two segments of the recombinant
plasmid, a 252 bp segment of the phleomycin resistance conferring
ble gene (GenBank ID: X52869) and an approximately 1 kb DNA
fragment containing parts of both the OD and ble genes and the
intergenic region. To that end, the ble-specific forward primer 59–
AGTTGACCAGTGCCGTTCC–39 and reverse primer 59–
CGGAAGTTCGTGGACACGA–39 were used and the OD gene
specific forward primer 59–GACATGTTTCAGCTTTTCCTC–
39 and the ble-specific reverse primer 59–CGGAAGTTCGTG-
GACACGA–39. The PCR reactions were performed using the
Figure 4. Changes of the fatty-acid profile of procyclic-form trypanosomes upon RNA interference of oleate desaturase expression.
Procyclic cell line 29-13 (wt PCF) and the cell line containing the OD RNAi construct were grown in the absence (-tet) or presence (+tet) of tetracycline
during the indicated time. The abundance of each fatty acid is presented as percentage of the total fatty acids. C16:0, palmitate: C16:1, palmitoleate;
C18:0, stearate; C18:1, oleate; C18:2, linoleate; UFAs, unsaturated fatty acids. The results are means 6 SD of three independent experiments.
doi:10.1371/journal.pone.0014239.g004
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60uC and with 35 cycles. Amplified products were analyzed by
electrophoresis on 1% agarose gels. No amplification products
were obtained when wild-type cell DNA was used in the PCR
reactions.
For induction of double-stranded RNA, PCF and BSF cells
were cultured in appropriate medium containing 1 mg/ml of tet.
To assess the RNA knockdown, a semi-quantitative assay for
mRNA was performed. Parasites were harvested from 20 ml of a
PCF culture (10
7 cells/ml) and 100 ml of a BSF culture (10
6 cells/
ml) after induction with tet at each 24 h during four days. Cells
were collected by centrifugation at 2,0006g and washed twice with
10 ml of ice-cold phosphate buffered saline. Wild-type PCF and
BSF cells were used as controls. Total RNA was extracted using
the SV Total Isolation System Kit of Promega and subsequently
cDNAs were synthesized with the RevertAid H Minus First Strand
cDNA Synthesis Kit of Fermentas. These cDNAs were synthesized
using appropriate primers: for OD the forward and reverse primers
were 59–TAATGCCATTGAGGTAAC–39 and 59–TGCGAG-
TAATGCAGATCC–39, respectively. Tubulin was amplified for
normalization purpose utilizing the oligonucleotides 59–GC-
GCGAAATCGTCTGCGTTCAGG–39 and 59–GCACGTAC-
GGAGTCCATTGTACC–39 as forward and reverse primers,
respectively. PCR experiments were performed with the GoTaq
DNA polymerase (Promega) at 58uC using 18 cycles for BSF, 26
cycles for PCF and 18 cycles for the tubulin amplification (the
number of cycles were chosen in order to avoid saturation of the
signal). The amplified fragments were resolved on 2% agarose gels
and subsequently visualized by treatment for 20 min with Sybr
Safe DNA Gel Staining (Invitrogen). The gel was then scanned
with a Kodak image station 2000MM and the relative amount of
amplification products was analyzed by densitometry. This
procedure was calibrated to assure a signal proportional to the
amount of DNA. The intensity of the bands of interest was
corrected by the intensity of the tubulin band amplified from the
same cDNA. Results obtained for RNAi induced cells were
expressed as percentages of those obtained for wild-type cells.
Results
Effect of 12- and 13-thiastearates on procyclic-form T.
brucei
We have previously identified and characterized the OD of T.
brucei [11]. The enzyme is a typical methyl-end desaturase, highly
similar to fungal and plant ODs [25]. Its gene (GenBank ID:
AY372529, protein ID: AAQ74969; GeneDB ID: Tb927.2.3080,
http://www.genedb.org) was expressed in Saccharomyces cerevisiae,
where the enzyme showed an absolute requirement for
cytochrome b5 as electron donor and a high specificity for oleate
as substrate. An important role of OD in T. brucei is in agreement
to the FA profiles shown in Fig. 1 and Table 1, with C18:2
representing 30% of total FAs in PCF and 34% in cultured BSF;
other di-unsaturated FAs represent less than 1% of total FAs. The
T. cruzi (AAR23833) and L. major (CAJ06920) orthologues share
61% and 58% of identity, respectively, with T. brucei OD. We
have shown recently that OD activity in T. cruzi can be
specifically inhibited by 12- and 13-TS, which is most probably
the reason of the growth inhibition of epimastigote (i.e. insect
stage) cultures, due to a drastic reduction of the essential FA
linoleate in the parasite membrane [13]. The high similarity
between ODs of both trypanosome species prompted us to assay
the toxicity of TS isomers on T. brucei PCF cultures. As shown in
Fig. 2, growth of PCF was totally inhibited by 100 mM 13-TS,
with an EC50 of 3062 mM. 12-TS has the same effect (EC50 of
4062 mM) which was not reverted by supplementing the medium
with oleate or linoleate up to 1 mM; higher concentrations of FAs
cannot be assayed as they are toxic even in the control
experiment without inhibitor (data not shown). Such toxic effect
of free FAs was not observed on T. cruzi epimastigotes [13]. After
30 h of growth in the presence of 100 mM TSs, the FA profiles of
the cells were determined by GC-MS. A notable drop in linoleate
level was found, from 30.7% (control) to 13.3% (12-TS) and
11.9% (13-TS) (Table 1). The levels of oleate and palmitoleate
(C16:1) did not show major variations whereas stearate slightly
increased from 10.4% to approximately 13%. The conversion of
oleate to linoleate was reduced from 65% to 38–42% which is
indicative of T. brucei OD inhibition. However, an inhibitory
effect on SCD cannot be ruled out, as the cells maintained
normal levels of oleate, which was expected to be increased after
Figure 5. Effect of thiastearates on the growth of bloodstream-
form Trypanosoma brucei. Growth curves are presented of BSF cells
cultured in the absence (control BSF) or presence of increasing
concentrations of 12-thiastearate (12-TS) (A) and 13-TS (B). The results
are means 6 SD of three independent experiments.
doi:10.1371/journal.pone.0014239.g005
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which could be an adaptation of the cell in order to maintain a
normal membrane fluidity, by replacing unsaturated FAs, which
dropped from 49% to 33–34%, by shorter saturated FAs; a
similar effect was previously also found in T. cruzi [13]. A 40%
reduction in linoleate content was only seen after treatment with
20 mM of 13-TS for 14 h (data not shown).
RNA interference of oleate desaturase in procyclic-form T.
brucei
To confirm the essentiality of OD, its expression was knocked
down by RNAi. To this end, plasmid constructs were prepared for
expression of double-stranded RNA corresponding to the 59-half
of the OD structural gene. Linearized plasmid DNA, constitutively
expressing the phleomycin-resistance marker gene, was stably
integrated into the T. brucei genome. RNAi was induced by the
addition of tet to the cultures, resulting in partial depletion of the
targeted OD from the trypanosome cells. The growth rate of cells
containing the RNAi construct was affected very early, even
without induction with tet, indicating a leaky regulation of double-
stranded RNA production from the T7 promoters in our system.
Normal growth rate did not resume within 329 h but induced and
non-induced cultures showed the same rate of growth, twofold
lower than that of wild-type (wt, not transfected) cells (Fig. 3A).
Levels of OD transcripts, normalized to the apparently stable
mRNA levels of the non-targeted tubulin, were decreased even in
non-induced cells, confirming the leaky regulation; an additional
and progressive loss was evident from 24 to 96 h of growth after
RNAi induction, below 40% of that in wild-type cells (Fig. 3B).
The selection of phleomycin resistant cells was very difficult, yet
cloned lines specifically and stably resistant to concentrations of
this antibiotic that killed wild-type cells could be obtained (see
Materials and Methods), but they all showed the leaky effect.
These findings, together with the inability to completely knock
down the expression of the gene and the drastic effect on growth
rate, even considering that the enzyme activity was only partially
ablated, indicate that OD is most probably essential in the PCF of
T. brucei. The uptake of FAs from the culture medium was not
effective in reverting such effect; supplementing the medium of the
induced culture with linoleate was equally ineffective, like before
for TS-treated cells (data not shown).
The FAs profiles of cells were analyzed by GC-MS. As shown
in Fig. 4, we found a drastic reduction of linoleate from 30.8% in
wild-type to 16.2% in non-induced transfected cells. An
additional and progressive drop was found till 12.6% after RNAi
induction for 96 h. The conversion of oleate to linoleate was
66.8% in wild-type cells, 32.3% in non-induced transfected cells
and 25% after 96 h induction. The stearate content was 10.8%,
8.1% and 7.6%, respectively for the same conditions. Interest-
ingly, total unsaturated FAs were slightly increased, due to a
considerable increase of oleate (from 15.3% to 34–38%), the
substrate of OD, which was even larger than the decrease in
linoleate level. This response of the cells to knocking down the
Figure 6. Effect of 13-thiastearate on the incorporation of radioactivity in membrane lipids of bloodstream-form Trypanosoma brucei
from radiolabeled fatty acids. BSF cells were preincubated for 30 min with 50 mM 13-TS, then incubated with [
14C]-oleate (A) or [
14C]-stearate (B)
for 1 h. The lipids were extracted by phase partitioning and fatty acids were analyzed by argentation-TLC after transmethylation, as described in
Materials and Methods. The radioactive spots were scraped from the plate and quantified by liquid scintillation radioassay. The abundance of each
fatty acid is presented as the percentage of sum of oleate (C18:1) and linoleate (C18:2) (A) or the sum of stearate (18:0), C18:1 and C18:2 (B). The
results are means 6 SD of three independent experiments.
doi:10.1371/journal.pone.0014239.g006
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after TS treatment of the trypanosomes, which reinforces the
possibility that SCD was also partially inhibited by 12- and 13-
TS. C16:0 showed a slight increase upon OD knockdown, which
can be explained by assuming the absence of a requirement to
increase this short FA for maintaining the physiological
membrane fluidity, as the total unsaturated FAs remained near
normal levels, even after 96 hours of RNAi.
Effect of 12- and 13-thiastearates on bloodstream-form T.
brucei
To evaluate T. brucei OD as a drug target, we tested the toxic
effect of TSs on cultures of the mammalian infective BSF of the
parasite. Fig. 5 shows that 50 mM of both TSs totally inhibited
trypanosome growth, with EC50values of 763 and 261 mM for 12-
and 13-TS, respectively. Growth phenotype was not reverted by
exogenous oleate or linoleate. Throughout the experiment the
indicated concentration of drugs was maintained by adding them at
eachdilution of the culture, every 24 h. In a separate experiment, in
which only one dose of drugs was added at the beginning of the
growth of the cultures, inhibition was observed as well, although
with an apparent EC50 of only 6065 mM for 13-TS. The effect of
12- and 13-TS appears to be trypanocidal for both the BSF and
PCFofT.brucei.Bymicroscopal examinationofthetreatedcultures,
a decreased motility of the cells and abundant accumulation of cell
debris were detected. Live cells with aberrant morphology were not
particularly notorious as compared to non treated control cultures.
It is interesting to note that treatment with the 10-TS isomer, which
is a specific inhibitor of SCD (data not shown), produces a different
phenotype, with an increased number of aberrant multiflagellated
cells displaying reduced motility, and a very low cell-debris
accumulation, most probably as consequence of a trypanostatic
effect. It indicates that the phenotype is not related to the chemical
nature of the used compound but to its target.
As T. brucei BSF reaches the stationary phase of growth at a cell
density one order of magnitude lower than PCF, analysis of the FA
profile of the BSF cells by GC-MS was considered not realistic
because of the high amounts of drugs that would be required. We
have set up a whole cell radiolabeling assay to circumvent this
experimental limitation. This method allows the analysis of the
inhibitory effect of drugs within minutes instead of hours,
identifying a direct effect on the putative targets before the cells
react by modifying their FA composition to sustain normal
membrane functions. T. brucei BSF cells (10
7) were preincubated
during 30 min with 50 mM of 13-TS, then incubated during
60 min with [
14C]-oleate or [
14C]-stearate. Total lipids were
extracted and FAs analyzed by argentation-TLC after transmeth-
ylation. As shown in Fig. 6A, 13-TS strongly inhibited OD, as
20.4% of exogenous oleate was converted to linoleate in control
cells whereas it dropped to 7.7% in treated cultures. A low but
significant inhibition of SCD was detected as well, with a drop
from 23.1% to 19% in the conversion of exogenous stearate to
oleate (Fig. 6B).
RNA interference of oleate desaturase in bloodstream-
form T. brucei
The experiments described above indicate that OD is expressed
in BSF, and is essential for normal growth. In order to confirm it
we knocked down the expression of OD in BSF cells in a similar
way as indicated for PCF trypanosomes and by using the same
DNA construction. Its insertion in the trypanosome’s genome was
evidenced by amplification of the phleomycin-OD gene cassette
from purified genomic DNA, whereas no such amplification was
found for control wild-type cells (not shown). The results are
equivalent to those found for PCF cells. Again, selection of
phleomycin resistant cells was difficult and cloned cell lines showed
the leaky effect. Induced and noninduced cells presented identical
growth rates, nearly twofold slower than wild-type cells (Fig. 7A).
Although the level of OD mRNA, normalized to the tubulin
mRNA level in the same samples, was always above 48% of that in
wild-type cells (Fig. 7B) even after 96 h of induction, the content of
linoleate was reduced from 33.5% to 26.5% (Fig. 8). It indicates
that the ablation of OD is highly deleterious to the cell even when
the activity was reduced by a mere 8%.
We assayed the effect of drugs on OD-knocked down cells after
72 h of RNAi induction by tetracycline. The EC50 values were
1.960.05 and 0.6960.03 mM, respectively for 12-TS and 13-TS.
It represents 3.7-2.9 fold lower values compared to those found for
wild-type cells. In contrast, the known trypanocidal drug Suramin
did not show exacerbated toxicity on interfered cells as compared
to wild-type parasites (EC50 values of 0.3860.06 and
0.4060.07 mM, respectively). Such synergic effect between the
Figure 7. RNA interference of oleate desaturase expression in
bloodstream-form trypanosomes. Growth curves (logarithmic plot)
of bloodstream form cell line 90-13 wild-type (wt BSF) and cells
transfected with a construct for RNAi of OD. Cells of the transfected
clone were cultured in the absence (-tet) and presence of tetracycline
(+tet) to induce RNAi (A). Relative levels of OD mRNA normalized to
tubulin mRNA levels. The results are expressed as percentage of the
normalized OD transcripts present in the untransfected control (wt)
cells and are the means 6 SD of three independent experiments (B).
doi:10.1371/journal.pone.0014239.g007
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having their impact on the same target.
Discussion
Total FAs of T. brucei can be separated in two well differentiated
pools by gas chromatography (Fig. 1): pool 1 which includes
middle- and long-chain FAs, and pool 2 formed by C20 and C22
PUFAs with up to six double bonds. A fraction of the FAs present
in pool 1 are those taken up from the culture media but a main part
of them represent FAs synthesized de novo by the unprecedented
pathway described in Introduction [3]. It implies the elongation of
a C4 primer of unknown metabolic origin by the particulate ELO
system, resulting in the synthesis of myristoyl-CoA, palmitoyl-CoA
and stearoyl-CoA. The latter two acyl-CoAs are desaturated by
SCD which is highly specific for stearoyl-CoA (Alloatti and Uttaro,
unpublished results). Saturated and D9 desaturated moieties are
then esterified to membrane lipids where oleoyl moieties are
desaturated by OD, which is highly specific for oleate [11]. It
results in the accumulation of linoleate, the most abundant FA
found in trypanosomes. On the other hand, FAs present in pool 2
result only from the uptake and modification of FAs from the host
or culture media and which are further desaturated and/or
elongated by trypanosome’s enzymes [8,12]. The independence of
both pools can be confirmed after inhibition of OD, as the sum of
FAs in pool 2 remains invariable, around 25% (Table 1) or after
knocking down the enzyme (not shown).
Membrane fluidity is mainly regulated by balancing the
proportion of unsaturated and saturated FAs of phospholipids.
This parameter is essential to maintain the correct functionality of
the bilayer, highlighting SCD and OD as key enzymes for such
regulation. Our RNAi experiments indicate that OD is expressed
in both life-cycle stages of the parasite (PCF and BSF) and that a
partial inhibition of its expression produced drastic effects on
growth (Fig. 3 and 7). Similar effects were seen by knocking down
the SCD (Gupta et al, unpublished results), indicating that both
desaturases are promising targets for chemical intervention, in
particular OD, as mammals lack this activity. Our RNAi
experiments on PCF are particularly informative with regard to
the basic lipid composition for normal membrane functionality.
One would expect that a deleterious effect on growth would result
from a change in membrane fluidity due to a drop of total
unsaturated FAs. Growth of PCF cells in which OD synthesis was
targeted by RNAi was indeed affected, but the total pool of
unsaturated FAs was maintained at a constant level, but with a
decreased linoleate and increased oleate content. This indicates
that not only fluidity but a normal content in one of the membrane
components (linoleate) could be essential for such functionality.
We have previously found that 12- and 13-TS specifically inhibit
T. cruzi OD and growth of epimastigote forms of the parasite [13].
Our results indicate that the T. brucei BSF was more sensitive to
these drugs, as 50 mM was sufficient to completely inhibit its
growth, with EC50 values of 763 and 261 mM, respectively
(Fig. 5), nearly one order of magnitude lower than that found for
the PCF (this work) or T. cruzi epimastigotes [13]. However, T.
brucei SCD was slightly inhibited by the TS as well, causing oleate
to remain constant at the expense of a considerable drop of
linoleate, as shown for PCF cells in Table I. This could explain
part of the parasite’s growth sensitivity to TSs. The decreased
linoleate content in TS-treated cells may have caused the cells to
attempt maintaining the membrane fluidity by increasing their
level of shorter saturated FAs, notably 16:0.
The combination of such sensitive target and the use of drugs
like thiastearates, which are of relatively simple chemical synthesis
and low toxicity [14,26], could be particularly useful, because it
may allow developing countries to produce locally the drugs in an
economically interesting manner, for treatment of these neglected
diseases.
An additional consequence of our RNAi experiments was the
confirmation of the identity of the OD gene, which we have
Figure 8. Changes of the fatty-acid profile of bloodstream-form trypanosomes upon RNA interference of oleate desaturase
expression. Bloodstream-form cell line 90-13 (wt BSF) or the cell line containing the OD RNAi construct grown in the presence of tetracycline (tet)
during 96 h. The abundance of each fatty acid is presented as percentage of the total fatty acids. C16:0, palmitate: C16:1, palmitoleate; C18:0,
stearate; C18:1, oleate; C18:2, linoleate; UFAs, unsaturated fatty acids. The results are means 6 SD of three independent experiments.
doi:10.1371/journal.pone.0014239.g008
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biochemical characterization of the expressed protein [11]. One
important conclusion of our previous work was that cytochrome b5
is the electron donor for the desaturase reaction and that the
cytochrome b-like domain of SCD can act as an alternative
electron donor. As our results show that OD is active in the BSF, it
is indicative that a cytochrome b5 or the equivalent domain of T.
brucei SCD (which is equally active in the BSF) has to be functional
in transferring electrons. For a number of years, it was believed
that BSF trypanosomes lack cytochromes. However, Vanhollebeke
et al. [27] demonstrated recently in T. brucei BSF the presence of
receptors specifically designed to acquire heme by internalizing
hemoproteins from the host plasma.
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